Iris Dorbian Wrote A New Post, Iconic Therapeutics Fetc...
Iconic therapeutics, a biopharmaceutical company focused on serious eye disorders, has raised $40 million in Series C funding. The investors included HBM Healthcare Investment...
Iconic therapeutics, a biopharmaceutical company focused on serious eye disorders, has raised $40 million in Series C funding. The investors included HBM Healthcare Investment...
Accelerator Corp has formed Lodo therapeutics Corp, which has secured $17 million in Series A funding. The investors included AbbVie, Alexandria Venture Investments, ARCH Vent...
Aelix therapeutics, la primera empresa surgida del consorcio Hivacat de desarrollo de tratamientos contra el VIH, ha conseguido financiación de 11,5 millones de euros que des...
Zacks Investment Research cut shares of Paratek Pharmaceuticals Inc (NASDAQ:PRTK) from a hold rating to a sell rating in a research note released on Sunday morning, Analyst Ra...
Shares of CymaBay therapeutics Inc (NASDAQ:CBAY) have been assigned a consensus broker rating score of 1.00 (Strong Buy) from the two analysts that cover the company, Zacks In...
SMi Group reports (07.01.2016, London): SMi caught up with key speaker Deborah Lee, VP of Clinical Development from INSYS therapeutics, Inc. [PR.com]
San Diego-based Abide therapeutics announced the appointment of Dr. Chan Beals as chief medical officer.
http://sdbj.com/news/2016/jan/08/abide-therapeutics-appoints-beals-chief-medical-of/
The muscarinic acetylcholine receptor subtype 1 (M1) receptors play an important role in cognition and memory, and are considered to be attractive targets for the development ...
http://jpet.aspetjournals.org/cgi/content/short/356/2/293?rss=1
FIERCEBIOTECH | Moderna therapeutics, a high-profile private biotech with scores of preclinical projects, is finally moving toward human trials, recruiting one of the world's...
By Ameet Sarpatwari and Aaron S. Kesselheim Each month, members of the Program On Regulation, therapeutics, And Law (PORTAL) review the peer-reviewed medical literature to...
[http://medcitynews.com/2016/01/c4-therapeutics-launches-with-73m-series-a-for-new-cancer-treatment-approach/] The startup created from Dana-Farber Cancer Institute announce...
(EMAILWIRE.COM, January 07, 2016 ) Denver, Colorado -- Sufferers of Plantar Fasciitis can now receive targeted arch relief using precision compression technology without medic...
http://www.emailwire.com/release/218003-Epsolux-Releases-New-Home-Remedy-For-Plantar-Fasciitis-.html